Mr. Rydzewski is a private investor who serves as advisor and director to healthcare companies and health policy and education organizations. As an investment banker at Solomon Partners, Benedetto, Gartland & Co., Kidder Peabody, Inc. and Dean Witter Reynolds Inc., he provided advisory and capital raising services for healthcare and life science companies in biotech and drug development services; hospital management and long-term care, including assisted and skilled nursing care; behavioral health and managed care. In addition to investment banking, he founded a pre-clinical-stage biotech company developing cancer-targeting immuno-therapeutics using technology licensed from MIT and Harvard University. He was a Managing Director focused on structured credit investments in the pharmaceutical sector at Christofferson Robb & Company. He was the senior manager in the bankruptcy and insolvency group, performing both creditor committee and debtor assignments, at Price Waterhouse & Co.